LLY

879.51

-2.09%↓

JNJ

239.74

+0.04%↑

ABBV

209.86

-0.59%↓

NVS

148.06

-1.14%↓

MRK

119.75

+0.73%↑

LLY

879.51

-2.09%↓

JNJ

239.74

+0.04%↑

ABBV

209.86

-0.59%↓

NVS

148.06

-1.14%↓

MRK

119.75

+0.73%↑

LLY

879.51

-2.09%↓

JNJ

239.74

+0.04%↑

ABBV

209.86

-0.59%↓

NVS

148.06

-1.14%↓

MRK

119.75

+0.73%↑

LLY

879.51

-2.09%↓

JNJ

239.74

+0.04%↑

ABBV

209.86

-0.59%↓

NVS

148.06

-1.14%↓

MRK

119.75

+0.73%↑

LLY

879.51

-2.09%↓

JNJ

239.74

+0.04%↑

ABBV

209.86

-0.59%↓

NVS

148.06

-1.14%↓

MRK

119.75

+0.73%↑

Search

Globus Medical Inc (Class A)

Atidarymo kaina

SektoriusSveikatos priežiūra

83.91 -3.13

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

82.29

Max

86.55

Pagrindiniai rodikliai

By Trading Economics

Pajamos

22M

141M

Pardavimai

57M

826M

P/E

Sektoriaus vid.

22.247

57.05

Pelnas, tenkantis vienai akcijai

1.28

Pelno marža

17.013

Darbuotojai

6,000

EBITDA

29M

244M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+26.31% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-05-07

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-819M

12B

Ankstesnė atidarymo kaina

87.04

Ankstesnė uždarymo kaina

83.91

Naujienos nuotaikos

By Acuity

50%

50%

164 / 349 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Globus Medical Inc (Class A) Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-26 23:43; UTC

Rinkos pokalbiai

Nikkei May Decline Amid Uncertainty Over Iran Peace Talks -- Market Talk

2026-03-26 23:36; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Gold Rises Amid Signs of Easing Middle East Tensions -- Market Talk

2026-03-26 23:35; UTC

Įsigijimai, susijungimai, perėmimai

Pernod Ricard: Confirms Discussions With Brown-Forman

2026-03-26 23:29; UTC

Uždarbis

Haier Smart Home: Company to Finance Share Buybacks Via Internal Funds >600690.SH

2026-03-26 23:28; UTC

Uždarbis

Haier Smart Home Plans A Share Buybacks of CNY3.0B-CNY6.0B >600690.SH

2026-03-26 23:28; UTC

Uždarbis

Haier Smart Home Plans to Increase Payout Ratio to 60% for 2027, 2028 >600690.SH

2026-03-26 23:28; UTC

Uždarbis

Haier Smart Home Plans Cash Dividend Payout Ratio of Up to 58% for 2026 >600690.SH

2026-03-26 23:27; UTC

Uždarbis

Haier Smart Home 2025 Net CNY19.55B Vs. Net CNY18.73B >600690.SH

2026-03-26 23:27; UTC

Uždarbis

Haier Smart Home 2025 Rev CNY302.33B Vs. CNY286.01B >600690.SH

2026-03-26 23:08; UTC

Rinkos pokalbiai

Infratil's Investor Day Addresses Data-Center Issues -- Market Talk

2026-03-26 23:04; UTC

Įsigijimai, susijungimai, perėmimai

Pernod Ricard in Talks to Combine With Jack Daniel's Maker Brown-Forman -- WSJ

2026-03-26 23:04; UTC

Įsigijimai, susijungimai, perėmimai

Families Behind Pernod, Brown-Forman Would Each Likely Retain Significant Stakes, Source Says -- WSJ

2026-03-26 23:04; UTC

Įsigijimai, susijungimai, perėmimai

Pernod, Brown-Forman Discussing Mostly Stock Deal, Source Says -- WSJ

2026-03-26 23:04; UTC

Įsigijimai, susijungimai, perėmimai

Pernod-Brown-Forman Deal Announcement Could Be Weeks Away, Sources Say -- WSJ

2026-03-26 23:04; UTC

Įsigijimai, susijungimai, perėmimai

Pernod in Deal Talks With Brown-Forman -- WSJ

2026-03-26 22:41; UTC

Įsigijimai, susijungimai, perėmimai

Brown-Forman: No Agreement Has Been Reached as to Terms of Any Possible Pernod Ricard Transaction

2026-03-26 22:41; UTC

Įsigijimai, susijungimai, perėmimai

Brown-Forman: Synergies From Contemplated Pernod Ricard Combination Expected to Be Significant

2026-03-26 22:26; UTC

Uždarbis

Jiangxi Copper 2025 Rev CNY544.62B Vs. CNY516.61B >0358.HK

2026-03-26 22:26; UTC

Uždarbis

Jiangxi Copper 2025 Net CNY7.13B Vs. Net CNY6.96B >0358.HK

2026-03-26 22:26; UTC

Uždarbis

Jiangxi Copper Higher Demand For Products Supported Results>0358.HK

2026-03-26 22:08; UTC

Uždarbis

Air China 2025 Loss CNY1.79B Vs. Loss CNY232.56M >0753.HK

2026-03-26 22:08; UTC

Uždarbis

Air China Impairment Loss on Goodwill Weighed on Results>0753.HK

2026-03-26 22:08; UTC

Uždarbis

Air China 2025 Rev CNY171.48B Vs. CNY166.70B >0753.HK

2026-03-26 22:07; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Global Energy Roundup: Market Talk

2026-03-26 22:07; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Open-Pit Gold Miners Most Exposed to High Fuel Prices -- Market Talk

2026-03-26 22:00; UTC

Uždarbis

Tsingtao Brewery 2025 Net CNY4.59B Vs. Net CNY4.34B >0168.HK

2026-03-26 22:00; UTC

Uždarbis

Tsingtao Brewery: Higher Volume Sales of Beer Supported Results>0168.HK

2026-03-26 22:00; UTC

Uždarbis

Tsingtao Brewery 2025 Rev CNY32.47B Vs. CNY32.14B >0168.HK

2026-03-26 21:39; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope: Sees Early Indications of Strong Interest in Site Adjacent Western Port

2026-03-26 21:38; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope: Has Begun Expression of Interest Process For 65-Hectare Site Adjacent Western Port

Akcijų palyginimas

Kainos pokytis

Globus Medical Inc (Class A) Prognozė

Kainos tikslas

By TipRanks

26.31% į viršų

12 mėnesių prognozė

Vidutinis 110.33 USD  26.31%

Aukščiausias 123 USD

Žemiausias 90 USD

Remiantis 13 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Globus Medical Inc (Class A) kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

13 ratings

11

Pirkti

2

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

72.18 / 73.07Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Rinkos nuotaikos

By Acuity

164 / 349 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
help-icon Live chat